SCHEMBL13359374

SCHEMBL13359374

CC1C(N2CCN(C)CC2)c2cc(Cl)ccc2Sc2cccn21

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A3 Q01959 1/20 0.62
DRD2 P14416 3/20 0.52
HRH1 P35367 3/20 0.52
DRD4 P21917 2/20 0.52
HTR2C P28335 2/20 0.52
KCNK9 Q9NPC2 2/20 0.52
TP53 P04637 1/20 0.52
CYP1A2 P05177 1/20 0.52
CYP3A4 P08684 1/20 0.52
CYP2D6 P10635 1/20 0.52
TSHR P16473 1/20 0.52
NFKB1 P19838 1/20 0.52
CYP2C19 P33261 1/20 0.52
THPO P40225 1/20 0.52
HIF1A Q16665 1/20 0.52
NPC1 O15118 1/20 0.52
MTOR P42345 1/20 0.52
RAB9A P51151 1/20 0.52
RAD52 P43351 2/20 0.44
MEN1 O00255 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13359373 0.87 SLC6A3 (0.47) SLC6A3DRD2HRH1DRD4HTR2C
SCHEMBL13359372 0.84 SLC6A3 (0.45) SLC6A3DRD2HRH1DRD4HTR2C
SCHEMBL14393844 0.83 SLC6A3 (0.45) SLC6A3DRD2HRH1DRD4HTR2C
SCHEMBL13359371 0.82 SLC6A3 (0.43) SLC6A3CYP1A2TSHRCYP2C19MEN1
SCHEMBL3285765 0.77 SLC6A3 (1.00) SLC6A3DRD2HRH1DRD4HTR2C
SCHEMBL30978858 0.77 SLC6A3 (1.00) SLC6A3DRD2HRH1DRD4HTR2C
SCHEMBL13359375 0.71 MAPT (0.36) SLC6A3DRD2HTR2CTP53RAD52
SCHEMBL18310354 0.70 DRD2 (0.81) SLC6A3DRD2HRH1DRD4HTR2C
Clorotepine SCHEMBL678917 0.68 DRD2 (1.00) DRD2HRH1DRD4HTR2CKCNK9
Clorotepine SCHEMBL29822559 0.68 DRD2 (1.00) DRD2HRH1DRD4HTR2CKCNK9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7713956-B2 Dealkylated derivatives of pyrrolo[2,1-b]benzothiazepines with atypical antipsychotic activity SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. (IT) 2010-05-11 US disclosed
US-20070270402-A1 Dealkylated Derivatives of Pyrrolo[2,1-B]Benzothiazepines with Atypical Antipsy-Chotic Activity SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. (IT) 2007-11-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070270402-A1 Dealkylated Derivatives of Pyrrolo[2,1-B]Benzothiazepines with Atypical Antipsy-Chotic Activity CNR1, HRH4, CNR2 SLC6A3 405/4885DRD2 16/4885HRH1 5/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.